These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 12081987)

  • 21. Trial logistics, implementation, and conduct of the OCTAVE mega study in Germany. Prospective, randomised, double-blind study to compare the efficacy and tolerability of omapatrilat and enalapril.
    Kothny W; Kaaden R; Ludwig P; Chase D; Krekler M
    Arzneimittelforschung; 2004; 54(8):474-9. PubMed ID: 15460215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal hemodynamic and natriuretic effects of concomitant Angiotensin-converting enzyme and neutral endopeptidase inhibition in men.
    Regamey F; Maillard M; Nussberger J; Brunner HR; Burnier M
    Hypertension; 2002 Sep; 40(3):266-72. PubMed ID: 12215465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic and renal effect of chronic omapatrilat in sodium-restricted, one-kidney, one-clip hypertensive rats.
    Jover B; Stuit L; Mimran A
    J Hypertens; 2004 Feb; 22(2):383-8. PubMed ID: 15076198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure.
    Jiang XJ; O'Rourke MF; Zhang YQ; He XY; Liu LS
    J Hypertens; 2007 May; 25(5):1095-9. PubMed ID: 17414675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasopeptidase inhibition has potent effects on blood pressure and resistance arteries in stroke-prone spontaneously hypertensive rats.
    Intengan HD; Schiffrin EL
    Hypertension; 2000 Jun; 35(6):1221-5. PubMed ID: 10856267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in antihypertensive combination therapy: benefits of low-dose thiazide diuretics in conjunction with omapatrilat, a vasopeptidase inhibitor.
    Ferdinand KC
    J Clin Hypertens (Greenwich); 2001; 3(5):307-12. PubMed ID: 11588409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: the role of proximal aortic diameter and the aortic pressure-flow relationship.
    Mitchell GF; Lacourcière Y; Ouellet JP; Izzo JL; Neutel J; Kerwin LJ; Block AJ; Pfeffer MA
    Circulation; 2003 Sep; 108(13):1592-8. PubMed ID: 12975261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vasopeptidase inhibitors. Omapatrilat in hypertension and heart failure].
    Heinzl S
    Med Monatsschr Pharm; 2000 Feb; 23(2):38-41. PubMed ID: 10701306
    [No Abstract]   [Full Text] [Related]  

  • 29. [Vasopeptidase inhibition: a new mechanism of action--a new antihypertensive drug].
    Waeber B
    Praxis (Bern 1994); 2000 Apr; 89(16):649-53. PubMed ID: 10823018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of omapatrilat on hemodynamics and safety in patients with heart failure.
    Klapholz M; Thomas I; Eng C; Iteld BJ; Ponce GA; Niederman AL; Bilsker M; Heywood JT; Synhorst D
    Am J Cardiol; 2001 Sep; 88(6):657-61. PubMed ID: 11564390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omapatrilat in subtotal nephrectomy-salt hypertension: role of calcitonin gene-related peptide.
    Supowit SC; Zhao H; Wang DH; DiPette DJ
    Hypertension; 2001 Sep; 38(3 Pt 2):697-700. PubMed ID: 11566959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal effects of omapatrilat and captopril in salt-loaded, nitric oxide-deficient rats.
    Ying L; Flamant M; Vandermeersch S; Boffa JJ; Chatziantoniou C; Dussaule JC; Chansel D
    Hypertension; 2003 Nov; 42(5):937-44. PubMed ID: 14569001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.
    Rouleau JL; Pfeffer MA; Stewart DJ; Isaac D; Sestier F; Kerut EK; Porter CB; Proulx G; Qian C; Block AJ
    Lancet; 2000 Aug; 356(9230):615-20. PubMed ID: 10968433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the cardiovascular protection by omapatrilat and lisinopril treatments in DOCA-salt hypertension.
    Millette E; Demeilliers B; Wu R; Laplante MA; El Midaoui A; Moreau P; Lamontagne D; de Champlain J
    J Hypertens; 2003 Jan; 21(1):125-35. PubMed ID: 12544444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omapatrilat.
    Armstrong PW; Lorell BH; Nissen S; Borer J
    Circulation; 2002 Aug; 106(6):e9011-2. PubMed ID: 12187916
    [No Abstract]   [Full Text] [Related]  

  • 37. Vasopeptidase inhibition in a canine model of exercise-induced left ventricular dysfunction.
    Holzgrefe HH; Arthur SR; Powell JR
    Clin Exp Pharmacol Physiol; 2002 Aug; 29(8):696-703. PubMed ID: 12100002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasopeptidase inhibition: a new direction in cardiovascular treatment.
    Asher JR; Naftilan AJ
    Curr Hypertens Rep; 2000 Aug; 2(4):384-91. PubMed ID: 10981174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ACE/NEP inhibition on cardiac and vascular collagen in stroke-prone spontaneously hypertensive rats.
    Pu Q; Schiffrin EL
    Am J Hypertens; 2001 Oct; 14(10):1067-72. PubMed ID: 11710787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial.
    Dart AM; Cameron JD; Gatzka CD; Willson K; Liang YL; Berry KL; Wing LM; Reid CM; Ryan P; Beilin LJ; Jennings GL; Johnston CI; McNeil JJ; Macdonald GJ; Morgan TO; West MJ; Kingwell BA
    Hypertension; 2007 Jun; 49(6):1242-7. PubMed ID: 17470723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.